Growth Hormone Treatment Recruiting Phase 3 Trials for Somatotropin (DB00052)

IndicationStatusPhase
DBCOND0043256 (Growth Hormone Treatment)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06103513
Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in ChildrenTreatment